Todd Kenneth Rosengart, MD

Dr. Todd K. Rosengart, professor and chair of the Michael E. DeBakey Department of Surgery and DeBakey-Bard Chair of Surgery, is also professor of heart and vascular disease at the Texas Heart Institute and professor of molecular and cell biology at Baylor. He is an NIH-funded scientist with uninterrupted extramural funding since 1998. He is past president of the Society of Surgical Chairs, representing the academic chairs of surgery in North America, and is a member of the board of directors of the American Association for Thoracic Surgery, the world’s oldest society for cardiothoracic surgery. In 1997, Dr. Rosengart and his team at Cornell performed the world’s first viral-based cardiac gene transfer procedure, part of a landmark NIH and FDA-approved angiogenesis trial for “no option” patients with end stage coronary artery disease. He is PI of a cardiovascular surgery NIH T32 training grant, recipient of over $20 million in total research grants, holds fourteen issued U.S. patents (three additional patents pending) and is author of over 200 peer-reviewed articles and other publications with over 13,500 citations and an h-index of 62 (Google Scholar). He has mentored nearly 100 research and cardiac surgery trainees. Dr. Rosengart is past chair of the NIH Bioengineering, Technology and Surgical Sciences Study Section, chair of the American College of Surgeons National Surgeon Scientist Study Section, member of the Leducq Foundation Scientific Advisory Committee and a member of the American College of Surgeons Academy of Master Surgeon Educators. He is past editor of Seminars in Thoracic and Cardiovascular Surgery, serving since 2013. Amongst other affiliations, he is a member of the American Surgical Association and a fellow of the American College of Cardiology. Dr. Rosengart’s institutional roles include his serving as two-term chair of the BCM Faculty Group Practice Board of Governors and as a member of the Baylor St. Luke’s Medical Center Board of Directors. He previously served as board chair of the Affiliated Medical Services, a 1000-member consortium of BCM and University of Texas faculty staffing the Harris Health county medical system, one of the largest in the US. He also previously served as national chair of the cardiac surgery service line for CHI (now Common Spirit), a 140-hospital not-for-profit organization with 40 cardiac surgery programs, the largest not-for-profit hospital system in the US. Dr. Rosengart is co-founder of Vitals.com (MDx, LLC, which before its recent acquisition had become one of the world’s largest web-based medical consumerism companies. He is also co-founder of XyloCor Therapeutics, a $60 million gene therapy startup which recently successfully completed enrollment in an FDA Fast Track designated Phase 2 national trial of a “next-gen” angiogenic gene therapy for treating patients with end stage coronary artery disease. To make an appointment, please call (713) 798-5700. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted